Jubilant, which also produces various chemicals and adhesives, raised $200 million from a bought deal arranged by JPMorgan which offered the bonds on to investors at fixed terms which included a 50% conversion premium. It was the fourth time since May 2004 that the company has raised cash from the sale of equity or equity-linked instruments, including two previous CBs that will mature in 2009 and 2010 respectively.
The stock hasnÆt had the same spectacular share price gains as...
¬ Haymarket Media Limited. All rights reserved.
